Background-Stem cells are thought to enhance vascular remodeling in ischemic tissue in part
The immune response plays an important regulatory role in postnatal modification of the vascular system that occurs in response to ischemia. Inflammation and vascular remodeling not only share common signaling pathways, but there is also evidence that certain inflammatory cells such as monocytes can promote arteriogenesis in ischemic tissues. [1] [2] [3] In particular, a subset of "pro-angiogenic" monocytes may serve as a source for both pro-angiogenic cytokines and growth factors, and may participate in requisite remodeling of the extracellular matrix. 1, 4, 5 In recent years, there has been growing interest in using stem cells and differentiated progenitor cells as a treatment option for the growing number of patients with severe ischemic coronary artery disease (CAD) and peripheral arterial disease (PAD) who are not candidates for revascularization procedures. Understanding the mechanism by which these cells promote vascular remodeling is particularly important since clinical trials have varied considerably in their results. 6 Irrespective of whether or not they are incorporated into the native tissues, stem cells are able to act through local paracrine effects by secreting pro-inflammatory growth factors, cytokines, and chemokines. 7, 8 In animal models of myocardial infarction, improvement in ventricular function with allogeneic mesenchymal stem cell therapy has been linked with increased monocyte but not T-cell infiltration. 9 Yet little is known about the mechanisms of monocyte recruitment with stem cell therapy or its effect on vascular remodeling. In this study,
we hypothesized that progenitor cell therapy enhances vascular remodeling, in part, by upregulation of monocyte recruitment in ischemic tissue and rebalancing toward a more reparative immune response. To test this hypothesis, cell therapy with xenogeneic circulating multipotential adult progenitor cells (MAPC) was performed in a murine model of limb ischemia. 10 Non-invasive contrast-enhanced ultrasound perfusion and molecular imaging were used to evaluate in vivo temporal changes in blood flow, endothelial activation (P-selectin evascularization procedures. Understanding the mechanism by which these cel lls ls s p p pro romo mo mote te te vascular remodeling is particularly important since clinical trials have varied considerably in h hei ei ir r r re re resu sult lt lts. s. s 6 6 6 Ir rre re res sp spective of whether or not the ey y y ar r re incorporated ed d int to o th th the native tissues, stem r ce ell ls s are able t to o ac ac act th th hr roug ug ugh h h lo lo loca cal l p p pa ar ara ac cr ri ine e ef ff fect ts s b b by se se secr cre e etin in ng g p pr pro-o-in infl f f a am mma ma mat to tory ry g gro ro r w w wth h h fa a fact cto or o s expression), and intravascular recruitment of a pro-angiogenic subset of monocytes. For the latter, targeted imaging of the fractalkine receptor (CX 3 CR-1) was performed in order to specifically detect a population monocytes (Ly-6C lo , CX 3 CR-1 hi , Arginase-1-positive) that have been implicated in some studies as being immunomodulatory and pro-angiogenic in mice. 1, 4 Intravital microscopy and cell migration assays were used as complementary techniques to evaluate the effect of MAPC on endothelial-leukocyte interaction and monocyte chemotaxis.
Methods

Hindlimb Ischemia
The study was approved by the Animal Care and Use Committee at Oregon Health & Science
University. All studies with the exception of optimal imaging were performed in C57Bl/6 mice (Jackson Laboratories) age 8-10 weeks (n=77). Mice were anesthetized with inhaled isoflurane (1.0-1.5%). Unilateral hindlimb ischemia was produced by ligation of the distal common iliac artery and the origin of the epigastric artery through a midline abdominal incision using sterile technique. Mice were then recovered and buprinorphine HCL (0.2 mg/kg IM) was administered for analgesia.
MAPC Administration
Human MAPC (Athersys Inc., Cleveland, OH) were isolated and expanded as described previously were stored in liquid nitrogen until the day of use. 11 These cells are positive for CD29, CD49c, CD90 and MHC class I; negative for HLA class II CD34, CD45, CD80 and CD106; and have been shown to produce endothelial tube formation in vitro and in vivo. 11, 12 After thawing and washing, cell viability was assessed by trypan blue exclusion. One day after arterial ligation, the proximal ischemic hindlimb was injected with either 1×10 6 
MAPC
The study was approved by the Animal Care and Use Committee at Oregon Heal al lth th & & S S Sci ci cien en ence ce c
University. All studies with the exception of optimal imaging were performed in C57Bl/6 mice J Jac ac cks ks kso on on L L Lab ab abo orat at tor or orie i s) age 8-10 weeks (n=77). M M Mic c ce were anesthe he etize ed d d w w with inhaled isoflurane 1 1 1.0 0 0-1 -.5%). U Uni ni ila late tera ra al l hi hi hind nd ndli li limb m mb i isc sc sche hemi mia w w was s s prod od oduced ed ed b by y y l li iga gat t tio on on o of f f th h he e di di dis st stal al c c com om mmo m mon n n il l ilia i i c c c ar rte te tery ry ry a a and nd t t the he he o or ri igi gi in n o o of t t the he e ep p pig ig gas as astr tr tri ic ic a a art rt ter er ery y y th h hro ro rou u ugh gh h a a m m mid id idl li line ne e a ab bd bdom om omin in na al al i inc nc ncis is sio ion n n u u usin n ng st ster er ri ile e e echnique. Mi Mi Mice ce e w w wer er e e e e th th then n n r r rec e e ov ov over er e ed ed e a a and nd nd b b bup up upr r rin in inor or orph ph phin n ne e e HC HC HCL L L (0 (0 (0. suspended in 25 L of saline (n=28) whereas control animals received either sham saline injection (n=18) or no injection (n=22). Injections were made into the deep portion of the proximal hindlimb adductor muscles using high frequency (40 MHz) ultrasound guidance (Vevo 770, VisualSonics Inc.). In order to image the spatial distribution of the cell injectate in the first 5 treated animals, 1×10 4 non-targeted microbubbles were added to the cell suspension.
Immediately after injection, ultrasound imaging was performed with both high-frequency (40 MHz) 2-D imaging and contrast-specific low-power imaging (see below). Sequential short-axis planes were acquired from the inguinal fold to the knee using 0.25 mm adjustments in the elevational plane direction. High-frequency anatomic and contrast ultrasound image sets were digitally co-registered and 3-D rendered (OsiriX v3.5) to evaluate the spatial distribution of the injection.
Microbubble Preparation
Non-targeted lipid-shelled decaflourobutane microbubbles were prepared by sonication of a gassaturated aqueous suspension of 2 mg/mL distearoylphosphatidylcholine and 1 mg/mL of distearoylphosphatidylethanolamine-PEG(2000). For molecular imaging, biotinylated microbubbles were prepared by adding 0.4 mg/mL distearoylphosphatidylethanolamine-PEG(2000)-biotin. Biotinylated rat anti-mouse antibodies against P-Selectin (RB40.34) or CX 3 CR-1 (sc30030, Santa Cruz) was conjugated to the microbubble surface via a streptavidin linkage as previously described. 13 Microbubble concentration was measured by electrozone sensing (Multisizer III, Beckman Coulter).
Flow Cytometry
Microbubble attachment to monocytes was assessed by flow cytometry using bone marrow cells collected from the long bones of either wild-type mice or NR4A1 nuclear receptor-GFP reporter digitally co-registered and 3-D rendered (OsiriX v3.5) to evaluate the spatial dis str tr rib b bu utio io ion n n of of of t the he njection.
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Molecular Imaging
Molecular imaging of P-selectin and CX 3 CR-1 were performed on the same days as CEU perfusion imaging (3, 7, and 21 days after ligation). Intravenous injections of targeted microbubbles ( 1×10 7 ) were performed in random order. Low mechanical index (MI 0.18) images were acquired 8 min after each injection and the signal from retained microbubbles alone was determined as previously described by subtracting signal from the few remaining circulating microbubbles. 13 This was accomplished by digitally subtracting averaged frames obtained >10 seconds after destroying microbubbles within the beam volume with high mechanical index (1.2) imaging. Data were averaged for two adjacent but not-overlapping short-axis planes. All retained microbubbles within the limb were destroyed between injections by high power continuous imaging.
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Fluorescent Microangiography
Functional microvascular angiography was assessed in 3 mice from each treatment group at day 7 and 21. For these studies, mice received heparin (1,000 u/Kg) followed by 200 L of a 0.5 M solution of FITC-labeled lycopersicon esculentum lectin (Sigma Aldrich) by intravenous route.
Five minutes after injection, the descending aorta was cannulated through an abdominal approach, and perfusion fixation of the lower limbs was performed by infusion of 4% formalin at a perfusion pressure of 90-100 mm Hg. Tissues were embedded in egg albumin-gelatin matrix and 3-dimensional confocal fluorescent microscopy (FW1000, Olympus) was performed on 100 m sections using a full z-plane depth.
Optical Imaging
Optical imaging was performed to assess MAPC survival and function post-injection in 6
immune-competent mice with spontaneous albinism (Crl:CD1) and 6 beige severe combined immunodeficiency (SCID) mice with defective NK cells (CB17.Cg-Prkdc scid Lyst bg /Crl). For these experiments, 2×10 6 rat MAPC stably transfected with firefly luciferase using a lentivirus vector were injected 1 day after arterial ligation. At day 1, 2, 3, and 7 after injection, animals were anesthetized with inhaled isofluorane and luciferin (150 g/g) was injected by I.P route.
Optical imaging (IVIS Spectrum, Caliper Life Sciences) was performed 15 min after luciferin injection using medium binning and data were expressed as photons/s/cm 2 .
Immunohistochemistry
Histology was performed on perfusion-fixed paraffin-embedded sections. Sections were stained with Hematoxylin & Eosin for evaluation of inflammatory cell infiltration.
Immunohistochemistry was performed for monocytes/macrophages with a rat anti-mouse Mac-2 monoclonal antibody (M3/38, eBioscience) with an ALEXA Fluor-488-labeled secondary
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Intravital Microscopy
Intravital microscopy was performed to further assess the effects of MAPC on vascular leukocyte recruitment. Mice were randomized to one of the following treatment regimens performed two days prior to intravital microscopy: (A) intrascrotal injection of 1×10 
where C L is the systemic blood leukocyte concentration. In 4 additional mice, the degree of cremasteric ischemia was determined by ligation described above, placement of a catheter in the carotid artery which was advanced into the aorta, and intra-aortic injection of 4×10 
Monocyte Migration
Conditioned media was collected from MAPC plated at1 x10 6 cells/well grown under standard conditions for three days in the absence of serum. Human CD14+ monocytes were isolated from whole blood using a magnetic isolation kit (Dynabeads FlowComp, Invitrogen) and were confirmed to be CD14+ by flow cytometry. Either basal non-conditioned or MAPC-conditioned media (750 l) was placed in the bottom of 24-well 3 m pore Transwell plates (Costar) and 250 l of non-conditioned serum-free media containing 1.25×10 5 CD14 + monocytes were added to the inserts and monocyte migration to the wells was determined after 1 hr. Experiments were performed in triplicate with monocytes from different donors.
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Cytokine Assay
A multi-cytokine Ab array (RayBio® Biotin Label-based Human Antibody Array 1, Ray Biotech) was used to measure human cytokines from serum-free 3-day MAPC-conditioned medium.
Statistics
Analysis was performed using SAS 9. 
Results
Microvascular Remodeling and Flow Recovery
Arterial ligation resulted in a dusky color in the ischemic limb but distal toe necrosis did not occur. Microvascular blood flow in the ischemic hindlimb measured by CEU was reduced by approximately 75% by arterial ligation ( Figure 1A) . Three-dimensional rendering of the spatial distribution of the MAPC cell suspension after ultrasound-guided intramuscular injection on day 1 indicated that the suspension had distributed longitudinally in the deep portions of the proximal hindlimb adductor muscle group, extending from the inguinal region to knee ( Figure 1C) .
Injection of MAPC on day 1 resulted in a more rapid and complete recovery of microvascular was performed. Intravital microscopy data were non-normally distributed and we we ere re com om mpa pa pare re red d d by y
Mann-Whitney rank-sum test except for leukocyte rolling data which were compared using un npa pa pair ir ired ed ed S S Stu tu tud d dent nt t's 's s t t-test or Kruskal-Wallis for ev ev eval lu uation of trea atm tm men nt t t of of of treatment effects. A F Fish h her e 's exact t t te es st wa was s u us used ed ed t t to o o an anal al a y yz yze e e d d diffe er re e ence es s i in p p pro ro opo po ort tio ion ns. Figure 1D ). At day 21, muscle capillary density and capillary-to-myocyte ratio were slightly increased in the ischemic tissue from all groups compared to non-ischemic limbs (Supplemental Figure 1) ; however, there were no significant differences between MAPCtreated and untreated ischemic muscle.
MAPC Survival in the Ischemic Limb
Optical imaging of luciferase activity after injection of luciferase-transfected MAPC indicated that cells remained primarily within the injected limb (Figure 2 ). Activity declined progressively by two orders of magnitude between day 1 and day 7 suggesting either loss of cells or loss of protein production. The pattern of decay was not substantially different for immunecompetent and NK-deficient SCID mice, suggesting clearance of MAPC occurs similarly in the presence or absence of immune rejection. At day 7, luciferase activity was not significantly different from background levels in the majority of mice in both groups.
Molecular Imaging of Endothelial Activation and Monocyte CX 3 CR-1
CEU molecular imaging of P-selectin was used to assess endothelial response ( Figure 3A and and 21 ( Figure 1D ). At day 21, muscle capillary density and capillary-to-myoc cyt y yte e e ra ati ti tio o o we we were re lightly increased in the ischemic tissue from all groups compared to non-ischemic limbs Su Su upp pp pple le leme me ment nt ntal F F Fi ig igu ure 1); however, there were n n no significant dif f ffe f f renc nc ce es es between MAPCr rea a ate ted and un ntr tre e eat t ted d d is i ch ch chem em emic ic ic m mu us uscl cl c e e. .
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Optical imag ag gin in ng g g of of of l l luc uc cif if feras as ase e e ac c cti ti tivi vi v ty ty ty a a aft ft f er er er i i inj nj njec ec cti ti tion on on o of f lu lu luci ci cife fe fera ra rase se se-tra ra rans ns nsfe fe fect ct cted ed e M M MAP AP APC C C in i dicated by guest on July 26, 2017 http://circ.ahajournals.org/ Downloaded from 3B). P-selectin-targeted signal in the ischemic limb was significantly greater in MAPC-treated compared with both control groups at 3 and 7 days after arterial ligation. In MAPC-treated animals, signal was not confined to the initial distribution of cell injection and instead was uniformly distributed throughout the hindlimb adductor muscle group. P-selectin signal subsequently decreased by day 21 for all groups. There was a trend toward higher P-selectin signal in sham saline-injected versus non-treated control limbs at day 3 which did not reach statistical significance after correction for multiple comparisons. Monocyte CX 3 CR-1 signal on CEU molecular imaging in the ischemic limb was significantly higher for MAPC-treated compared to control groups at all time intervals ( Figure 3C ) and was also distributed uniformly throughout the muscle. There was no significant decline in CX 3 CR-1 signal between day 3 and 21. Preferential attachment of the CX 3 CR-1-targeted microbubbles to the intended monocyte population was verified by flow cytometry (Supplemental Figures 2-4 
Leukocyte Rolling on Intravital Microscopy
To corroborate the P-selectin expression patterns seen on molecular imaging, intravital microscopy was performed two days after intrascrotal injection of MAPC to assess selectinhroughout the muscle. There was no significant decline in CX 3 CR-1 signal betw tw wee e en da da day y y 3 3 3 an an a d Table 1) . Although leukocyte flux fraction was not significantly different between the groups, MAPC treatment resulted in greater flow velocity, greater flow rate, and hence a higher total number of rolling leukocytes. Together, intravital microscopy data suggest that in the presence of ischemia or a pro-inflammatory milieu, MAPC are able to migrate to a perivascular location where they promote leukocyte recruitment and probably migration.
Monocyte Migration and Cytokine Production
Cell migration assays performed to further examine whether products from MAPC promote monocyte migration. Migration of human monocytes was much greater in response to MAPCconditioned media compared to non-conditioned media (151±55 vs 6±3 cells per optical field, p<0.01). The cytokine array from conditioned media indicated the production of several key chemokines involved either directly or indirectly in monoycte chemotaxis and selectin ow density of MAPC. For ischemia studies, flow in the ischemic left cremaster r mu mu musc cle le le w w was as as 40±18% of that in the contraleratal control cremaster. In the ischemic cremaster muscles, venular e euk uk koc oc cyt yt yte e ro ro roll lling g g v ve velocity was slower in muscle es s s tr tre eated with MAP AP A C th th tha an an for sham-injected co on nt ntro r ls (Tabl ble e 1 1) ). A A Alt lt l ho ho oug ug gh h h le l leuk uk koc oc ocyt yte e f flux x x f fr r ractio ion n wa wa was s n no ot t s sig ig gni nifi fica can nt n l ly y d d dif if iff fe fere rent nt n b b bet et twe we ween en n t th h he t gr grou ou oups ps ps, , , MA MA APC P PC t tre reat atm m men nt nt r res sul ul u te te ted d d in in in g gre re r at at ater er er f flo lo low w ve ve elo o oci city ty ty, , , gr gr grea ea e te te er r fl fl flow ow w r r rat ate, e, a and nd n h h he en ence ce e a a a h hig ig ghe he er r otal number r o o of f f ro ro oll ll llin in i g g g le l l uk uk koc oc ocyt yt tes es es. T T Tog og get et the he her, r, , i int nt ntra ra ravi vi vita tal l mi mi micr cr cros os sc c cop o o y y y da da data ta ta s s sug ug ugge ge est st st t t tha ha hat t t in the 
Histology
On H&E staining of muscle from the ischemic hindlimb at day 3 and 7, there was a immune cellular infiltrate seen in all three treatment groups which was greater for the MAPC-treated group compared to control groups (Supplemental Figure 6) . On quantitative analysis of monocyte Mac-2 staining, there were pronounced differences between groups. For all three post-ligation study points, the area staining positive for Mac-2-positive cells was greater in MAPC-treated compared with control groups (Figure 5A and 5B). For all groups, monocyte infiltration peaked at day 7. MAPC produced a more diffuse rather than focal monocyte infiltration indicated by the greater number of sections with Mac-2-positive cells in MAPCtreated compared to control muscle ( Figure 5C ). On immunohistochemistry at the early time intervals, there were more Arg1-positive monocytes in the MAPC-treated than in control ischemic muscle (Figure 5D and 5E). The majority of monocytes stained positive for CX 3 CR-1 in all treatment groups. Although this did not allow us to confidently differentiate between CX 3 CR-1 hi and CX 3 CR-1 lo populations, MAPC-treated limbs were characterized by a greater number of cells in the muscle interstitium that stained strongly positive for CX 3 CR-1 ( Figure   5F ). Dual fluorescent staining demonstrated that most MAPCs that could be identified at day 3 had CX 3 CR-1-positive monocytes in proximity ( Figure 5G ).
Discussion
Stem cells and adult progenitor cells have been shown to promote beneficial vascular remodeling MAPC-treated compared with control groups ( Figure 5A and 5B d ). For all grou up ps ps, mo mo mono no nocy cy cyte te t nfiltration peaked at day 7. MAPC produced a more diffuse rather than focal monocyte n nfi fi ilt lt ltra ra ati ti tion on n i i ind nd n ic cat at ate ed ed by the greater number of se e ec ct c i io ons with Mac--2-2 2 po osi si sit ti tive v cells in MAPCr rea a ate ted compar ared ed ed t t to c co ont nt ntro ro ol l l mu mu musc scle le l ( (F Fi ig gu ure e 5 5C C). O O On i i im mm mmun un unoh ohi is st to och ch he em mi ist str ry ry a at t th th he ea ea e rl r r y y y ti time me me n nte te terv rv val al a s, s, , t the he here re w w wer er re e mo mo more re A Ar r rg1 g1 g1-p -p -pos os osit itiv iv ve e e mo mo mono no ocy cy cyte tes s in n n t t the he he M M MA A AP PC PC-t -t -tre re r a a ate ed d t th ha han n n in in n c c co o ontr tr rol ol l in ischemic tissues and in wound healing. One mechanism by which cell therapy potentiates angiogenesis is through their paracrine effects that involve the release of biomolecules that alter the local cellular and molecular environment. 7, 8 In a model of limb ischemia that was intended to reproduce a clinically-relevant situation of severe reduction in resting flow, we used a panel of techniques including in vivo CEU perfusion and molecular imaging to temporally evaluate how MAPC therapy augments recovery of perfusion and influences the recruitment of monocytes thought to promote arteriogenesis in ischemic tissues. Our results suggest that this population of adult progenitor cells promote monocyte entry into the skeletal muscle in part via a two-step process that involves increased endothelial recruitment through P-selectin expression and enhanced monocyte chemotaxis.
Stem and progenitor cells have been shown to have somewhat varied immunomodulatory
effects depending on the leukocyte cell type and local tissue environment. 18 Because MAPC produce chemotactic and endothelial activating factors, it is not unexpected that under certain conditions MAPC have been shown to stimulate a monocyte/macrophage response. 10, 19 Noteworthy findings of our study were the degree to which MAPC augmented monocyte infiltration, and how MAPC therapy dramatically altered the spatial characterization of the monocyte infiltrate, producing a much more uniform and diffuse distribution of monocytes than in untreated limbs. Monocytes that stained positively for Arg1 were preferentially recruited without an obvious increase in granulocyte infiltration on H&E staining, suggesting that cell therapy may rebalance the cellular immune response toward a more regenerative phenotype. A similar rebalancing of the cellular immune response has been described after injecting conditioned media from bone marrow-derived mesenchymal stem cells (BM-MSCs) in a model of wound healing. 20 enhanced monocyte chemotaxis.
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One aim of this study was to define the mechanism of enhanced pro-angiogenic monocyte recruitment with MAPC therapy. For evaluating endothelial activation, we studied Pselectin due to its important role in initiating the immune response through leukocyte capture and rolling. We used a P-selectin-targeted contrast agent that has been validated in multiple different models of ischemic disease. 13, 17, 21 An advantage of using CEU in this particular study is that targeted microbubble signal reflects only luminal surface expression of P-selectin rather than that which is stored pre-formed within the Weibel-Palade bodies. We have previously shown that the P-selectin signal in this model of limb ischemia is primarily from endothelial activation and not from platelets. 17 In MAPC-treated limbs, molecular imaging detected a significant increase in Pselectin expression at days 3 and 7. These findings were further substantiated by intravital microscopy where in venules of cremaster muscle that was either treated with TNF-or was rendered ischemic, MAPC resulted in slower leukocyte rolling velocity and increased number of rolling leukocytes indicative of increased selectin expression. 22 Intravital microscopy also provided convincing evidence that MAPCs promote the recruitment of certain immune cells by their ability to migrate to a perivascular position. Their migratory capacity may also explain why molecular imaging signal enhancement in MAPC-treated limbs was diffuse rather than localized to the region of cell distribution identified by imaging at the time of administration. An interesting and presently unexplained finding was the greater microvascular flow velocity in MAPC-treated ischemic muscles only several days after injection. This finding was corroborated by day 3 CEU perfusion data in ischemic limbs. These data imply a difference in the production of vasoactive compounds that may precede and promote structural vascular remodeling.
For temporal characterization of monocyte recruitment, we targeted microbubbles to electin expression at days 3 and 7. These findings were further substantiated by by y int nt n ra avi vi vita ta tal l l microscopy where in venules of cremaster muscle that was either treated with TNF-or was e end nd der er red ed ed i i isc sc sche h h mi mi ic c, c, M MAPC resulted in slower leu u uk k ko oc cyte rolling ve e elo l l ci ity ty y a a an nd increased number of o oll li in ing leukoc cyt yte e es ind nd dic i a at ati iv ive e e of o of in in ncr cr crea ease sed d se ele ectin n e ex xpr re res ss ssio io on n. . 22 22 2 In In ntr trav avit i a a al m m mi ic cr cros osc co copy py p als ls so o pr prov ov ovid id ided ed e c con on onvi vin nc cin n ng g ev e evi id ide enc ce ce t t tha ha hat t t M M MAP AP APCs Cs Cs p pro ro romo mo mote te e th he he r r rec ec ecru u uit it i m me men n nt t t of of f c cer erta ta ain in in i imm mm mmun une e e c ce cell lls s s by by by heir ability y to to o m m mig ig gra ra rate te e t t to o a a a pe pe peri iva va vasc sc scul u u ar ar ar p p pos os osit it itio io ion. n. n Th Th Thei e r r r mi mi migr gr grat at ator or ory y ca ca capa pa paci ci city ty ty m may ay ay a a als ls so o o ex e plain wh hy y CX 3 CR-1 in an attempt to image a subpopulation of monocytes thought to be pro-angiogenic and reparative. 1, 4, 23 The use of targeted microbubbles for molecular imaging ensured that signal originated from cells that were being actively recruited in the vascular space rather than reflecting cumulative extravasation. In part this could explain why molecular imaging signal for monocytes underestimated the differences between treatment groups seen on histology.
However, we believe that the greater treatment-related differences in monocyte recruitment on histology than molecular imaging could also be explained by the two step process of MAPC to increase endothelial cell adhesion molecule expression and to enhance monocyte chemotaxis.
The notion that MAPC enhance monocyte chemotaxis was supported by data from migration assays, intravital microscopy, histology, and MAPC cytokine and chemokine array. Although CD4+ and CD8+ T-cells and natural killer cells could also have contributed to the CX 3 CR-1 signal, 24 the degree of lymphocyte infiltration on histology was very small, suggesting that MAPC induce the specific recruitment of CX 3 CR-1-positive monocytes.
Optical imaging of luciferase activity suggested that MAPCs did not persist beyond a week after injection. While previous studies suggest that NK cells could be responsible for early cell clearance, 10 our optical imaging data and monocyte immunohistochemistry from SCID beige from cells that were being actively recruited in the vascular space rather than refl fl lec ecti ti t ng ng ng cumulative extravasation. In part this could explain why molecular imaging signal for mo mon no nocy cy cyte te tes s s un un nde ere re res st stimated the differences betwee ee een n treatment grou ou ups s see ee een n on histology.
H How we w ver, we be beli l e ev eve e th that a at t t the he he g g gre rea at ate er er t tre rea atm me en n nt-re ela a ated d d d di diff ff fe er eren enc ces s in in m m mo on noc oc cyt y yte e re re ecr r rui ui uitm tm tme en ent t on n n hi hist st stol ol olog og ogy y y th th han a an m m mol l lec ecu u ula ar r i ima ma agi gi ging ng ng c c cou oul ld ld a a als ls lso o o be be be ex ex xp pl plai ai ine ne ed indicate that most cell loss was not from immunologic "rejection" An intriguing observation was that certain indicators of immune activation, such as enhanced CX 3 CR-1 signal on molecular imaging and monocyte recruitment on histology, persisted late (day 21) despite the evidence on optical imaging that few MAPC survived at one week. However, it is known that the monocyte inflammatory response in ischemic limb tissue is self-amplifying. 25 Many monocyte/macrophage cell products are capable of perpetuating endothelial activation and monocyte recruitment.
Accordingly, we believe that a sustained monocyte response can be achieved with single administration of a chemokine stimulus such as intramuscular injection of MAPC. Although we did not specifically test which mediators were directly responsible for initiating these events, we did evaluate the MAPC secretome which indicated the presence of several key cytokines, CCchemokines, and growth factors (MCP-1, MIP-1 , VEGF, M-CSF, and IL-1 ) that have all been
shown to directly or indirectly increase P-selectin expression and/or monocyte chemotaxis. [26] [27] [28] [29] [30] It should be noted that results from microvascular perfusion in this study alone are important. Muscle CEU perfusion imaging has been used to evaluate pro-angiogenic therapies in animal models of disease. 31 As we have demonstrated, it provides information on perfusion at rest and during stress, and can measure the expansion of the microvascular blood volume which.
CEU blood volume data in conjuction with fluorescent microangiography and capillary histology suggested that the MAPC treatment increased flow primarily through remodeling of the distal arteriolar network which enhanced distribution of flow to parallel microvascular units.
There are several limitations of the study that deserve mention. The lack of luciferase activity beyond day 7 on optical imaging may have resulted from altered protein production rather than cell loss, although histology supported the latter. Our data does not provide definitive did not specifically test which mediators were directly responsible for initiating t the h hese s s e eve e vent nt nts, s, s w we did evaluate the MAPC secretome which indicated the presence of several key cytokines, CC- h h how w own to direc ctl tl ly y y o or or i i ind nd n ir ir irec ec ectl tl tly y y in incr cr cre ea eas se e P P-se ele ectin n e ex xpr re res ss ssio io on n an and/ d/or or m mon on noc ocyt yt yte e ch ch hem em emot ot tax ax xis is is. .
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I It t sh sh hou o ould ld be e e no no ote e ed d th that at a r res es esul ul ult ts ts f f fro ro rom m m m mi micr cr crov ov va as scu u ula a ar r r p pe perf rf rfus us u io ion n n in in i th hi his s st st stud ud udy y y a al alo o one e e ar r re e mportant. Mu Mu Musc sc s le le le C C CEU EU EU p per er e fu fu fusi si ion on on i i ima ma magi gi g ng ng ng h h has as as b b bee ee en n n u use se sed d d to to to e e eva va valu luat at ate e e pr pr pro-o-o an an a gi gi giog og ogen en enic ic ic therapies i in n information on how much of the vascular response to MAPC was attributable to monocyte recruitment. It should also be noted that there is some controversy regarding the identification of proangiogenic monocytes, with some reports suggesting that the "inflammatory subset" of monocytes that are CCR2 high may also contribute to angiogenesis in response to limb ischemia in mice. 25 The differences in flow and shear conditions could have influenced leukocyte rolling data on intravital microscopy experiments in ischemic muscle. However, data from TNF--treated muscle were generated under identical shear conditions and support the idea of enhanced rolling with MAPC therapy. Arguing against P-selectin as a mechanism for selective recruitment for "pro-angiogenic" monocytes, it has been shown that Ly-6C low CX 3 CR-1 high monocytes have slightly less cell surface expression of P-selectin glycoprotein ligand-1 when compared to their more inflammatory counterparts. 32 However, we believe that P-selectin is important for the initial microvascular capture for all monocytes and selective recruitment of one subtype is likely to involve specific chemotactic signals.
In summary, we have demonstrated that adult progenitor cell therapy with MAPC potentiates the pro-angiogenic monoycte response in limb ischemia which may, in part, explain their ability to promote flow recovery. These data will likely provide justification for future studies to evaluate the molecular mediators that are responsible for monocyte recruitment and to develop models that can test how much of the vascular response is attributable to monocytes. monocytes have slightly less cell surface expression of P-selectin glycoprotein l lig ig gan n nd-d--1 1 1 wh wh when en e f compared to their more inflammatory counterparts. 32 However, we believe that P-selectin is m mpo po port rt rta an ant t t fo fo for r the e e in in init i ial microvascular capture f for or or a a all monocytes a a and n s sel el ele ec ective recruitment of one Supplemental Figure Video 2b -Intravital microscopy of the same venule as in Video 2a using fluorescent epiillumination demonstrating the perivascular location of di-I-labeled MAPC.
